Rochester, NY 8/20/2009 5:50:39 PM
Pfizer Inc. PFE - Market Updates – Sinovac, Eli Lily, Pfizer, Merck
Pfizer Inc. PFE
Wednesday, China-based vaccine developers Sinovac Biotech Ltd. Makes an announcement that its a 74% increase in second-quarter profit, as sales grew 21% driven partly by increased sales of inactivated hepatitis A vaccine following a purchase order from China's Ministry of Public Health Ministry.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Pfizer Inc. in July reported a decline in net income for the second quarter to $2.26 billion, or $0.34 per share, from $2.78 billion, or $0.41 per share, in the same period last year. Eli Lilly & Co. LLY announced its raised earnings outlook for fiscal year 2009. Merck & Co. Inc. Reported a 12% decline in second-quarter profit to $1.59 billion, hurt mainly by lower revenues as well as merger and restructuring costs.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
